SYK
Stryker Corporation
NYSE: SYK · HEALTHCARE · MEDICAL DEVICES
$315.13
+0.00% today
Updated 2026-04-30
Market cap
$120.69B
P/E ratio
37.47
P/S ratio
4.81x
EPS (TTM)
$8.41
Dividend yield
1.06%
52W range
$311 – $402
Volume
2.0M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
8.0
Growth
A6.0
Quality
B7.5
Profitability
B+3.3
Valuation
D3/9
Piotroski F-Score
Weak
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$419.11
+33.00%
12-Month target
$253.71
-19.49%
Intrinsic (DCF)
$263.22
Margin of safety
-19.72%
8 Strong Buy13 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.88B — positive
+ Revenue growth 11.40% QoQ
Risks
- Piotroski 3/9 — weak financial health
- 19.72% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $18.45B | $20.50B | $22.59B | $25.12B | $25.12B | $27.6B |
| Net income | $2.36B | $3.17B | $2.99B | $3.25B | $849.00M | — |
| EPS | — | — | — | — | $8.41 | $15.12 |
| Free cash flow | $2.04B | $3.14B | $3.49B | $4.28B | $1.88B | — |
| Profit margin | 12.78% | 15.44% | 13.25% | 12.92% | 12.90% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-21 | WELLS, PRESTON WENDELL | Sale | 204 | $335.67 |
| 2026-03-21 | STILES, SPENCER S | Sale | 430 | — |
| 2026-03-21 | STILES, SPENCER S | Sale | 6,690 | $335.67 |
Peer comparison
Smart narrative
Stryker Corporation trades at $315.13. representing a P/E of 37.47x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.18, it sits in the grey zone. TTM revenue stands at $25.12B. with profit margins at 12.90%. Our DCF model estimates intrinsic value at $263.22.
Frequently asked questions
What is Stryker Corporation's stock price?
Stryker Corporation (SYK) trades at $315.13.
Is Stryker Corporation overvalued?
Smart Value Score 65/100 (Grade B, Buy). DCF value $263.22.
What is the price target of Stryker Corporation (SYK)?
The analyst target price is $419.11, representing +33.0% upside from the current price of $315.13.
What is the intrinsic value of Stryker Corporation (SYK)?
Based on our DCF model, intrinsic value is $263.22, a -19.7% margin of safety versus $315.13.
What is the future stock price of SYK by 2030?
Our research-backed model estimates Stryker Corporation could reach $1,160.39 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Stryker Corporation's revenue?
TTM revenue is $25.12B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
2.18 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio4.81x
ROE15.10%
Beta0.93
50D MA$347.75
200D MA$365.45
Shares out0.38B
Float0.35B
Short ratio—
Avg volume2.0M
Performance
1 week-3.78%
1 month-4.33%
3 months-14.73%
YTD-10.34%
1 year—
3 years—
5 years—